View in EDS PDF Full Text

Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group.

Saved in:
Bibliographic Details
Title: Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group.
Authors: Gregersen H; Department of Haematology, Aalborg University Hospital, Aalborg, Denmark., Peceliunas V; Department of Haematology, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania., Remes K; Department of Haematology, Turku University Hospital, Turku, Finland., Schjesvold F; Oslo Myeloma Center, Oslo University Hospital, Oslo, Norway.; KG Jebsen Center for B cell malignancies, University of Oslo, Oslo, Norway., Abildgaard N; Department of Haematology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark., Nahi H; Department of Haematology, Karolinska University Hospital, Stockholm, Sweden., Andersen NF; Department of Haematology, Aarhus University Hospital, Aarhus, Denmark., Vangsted AJ; Department of Haematology, Rigshospitalet, Copenhagen, Denmark., Klausen TW; Department of Haematology, Herlev Hospital, Herlev, Denmark., Helleberg C; Department of Haematology, Herlev Hospital, Herlev, Denmark., Carlson K; Department of Haematology, Uppsala University Hospital, Uppsala, Sweden., Frølund UC; Department of Haematology, Zealand University Hospital, Roskilde, Denmark., Axelsson P; Department of Haematology, Helsingborg Hospital, Helsingborg, Sweden., Stromberg O; Department of Haematology, Karolinska University Hospital, Stockholm, Sweden., Blimark CH; Department of Haematology, Sahlgrenska University Hospital, Göteborg, Sweden., Crafoord J; Department of Haematology, Örebro University Hospital, Örebro, Sweden., Tsykunova G; Department of Haematology, Haukeland University Hospital, Bergen, Norway., Eshoj HR; Quality of Life Research Center, Department of Haematology, Odense University Hospital, Odense, Denmark.; OPEN, Open Patient data Explorative Network, Odense University Hospital, Region of Southern Denmark, Denmark., Waage A; Department of Haematology, St Olavs hospital and Institute of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Hansson M; Department of Haematology, Skåne University Hospital, Lund, Sweden., Gulbrandsen N; Oslo Myeloma Center, Oslo University Hospital, Oslo, Norway.
Source: European journal of haematology [Eur J Haematol] 2022 Jan; Vol. 108 (1), pp. 34-44. Date of Electronic Publication: 2021 Oct 11.
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609 (Electronic) Linking ISSN: 09024441 NLM ISO Abbreviation: Eur J Haematol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34536308
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gregersen+H%22">Gregersen H</searchLink>; Department of Haematology, Aalborg University Hospital, Aalborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Peceliunas+V%22">Peceliunas V</searchLink>; Department of Haematology, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.<br /><searchLink fieldCode="AU" term="%22Remes+K%22">Remes K</searchLink>; Department of Haematology, Turku University Hospital, Turku, Finland.<br /><searchLink fieldCode="AU" term="%22Schjesvold+F%22">Schjesvold F</searchLink>; Oslo Myeloma Center, Oslo University Hospital, Oslo, Norway.; KG Jebsen Center for B cell malignancies, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Abildgaard+N%22">Abildgaard N</searchLink>; Department of Haematology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.<br /><searchLink fieldCode="AU" term="%22Nahi+H%22">Nahi H</searchLink>; Department of Haematology, Karolinska University Hospital, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Andersen+NF%22">Andersen NF</searchLink>; Department of Haematology, Aarhus University Hospital, Aarhus, Denmark.<br /><searchLink fieldCode="AU" term="%22Vangsted+AJ%22">Vangsted AJ</searchLink>; Department of Haematology, Rigshospitalet, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Klausen+TW%22">Klausen TW</searchLink>; Department of Haematology, Herlev Hospital, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Helleberg+C%22">Helleberg C</searchLink>; Department of Haematology, Herlev Hospital, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Carlson+K%22">Carlson K</searchLink>; Department of Haematology, Uppsala University Hospital, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Frølund+UC%22">Frølund UC</searchLink>; Department of Haematology, Zealand University Hospital, Roskilde, Denmark.<br /><searchLink fieldCode="AU" term="%22Axelsson+P%22">Axelsson P</searchLink>; Department of Haematology, Helsingborg Hospital, Helsingborg, Sweden.<br /><searchLink fieldCode="AU" term="%22Stromberg+O%22">Stromberg O</searchLink>; Department of Haematology, Karolinska University Hospital, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Blimark+CH%22">Blimark CH</searchLink>; Department of Haematology, Sahlgrenska University Hospital, Göteborg, Sweden.<br /><searchLink fieldCode="AU" term="%22Crafoord+J%22">Crafoord J</searchLink>; Department of Haematology, Örebro University Hospital, Örebro, Sweden.<br /><searchLink fieldCode="AU" term="%22Tsykunova+G%22">Tsykunova G</searchLink>; Department of Haematology, Haukeland University Hospital, Bergen, Norway.<br /><searchLink fieldCode="AU" term="%22Eshoj+HR%22">Eshoj HR</searchLink>; Quality of Life Research Center, Department of Haematology, Odense University Hospital, Odense, Denmark.; OPEN, Open Patient data Explorative Network, Odense University Hospital, Region of Southern Denmark, Denmark.<br /><searchLink fieldCode="AU" term="%22Waage+A%22">Waage A</searchLink>; Department of Haematology, St Olavs hospital and Institute of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.<br /><searchLink fieldCode="AU" term="%22Hansson+M%22">Hansson M</searchLink>; Department of Haematology, Skåne University Hospital, Lund, Sweden.<br /><searchLink fieldCode="AU" term="%22Gulbrandsen+N%22">Gulbrandsen N</searchLink>; Oslo Myeloma Center, Oslo University Hospital, Oslo, Norway.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228703985%22">European journal of haematology</searchLink> [Eur J Haematol] 2022 Jan; Vol. 108 (1), pp. 34-44. <i>Date of Electronic Publication: </i>2021 Oct 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Blackwell%22">Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8703985 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1600-0609 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209024441%22">09024441 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Haematol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34536308
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/ejh.13709
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 34
    Titles:
      – TitleFull: Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gregersen H
      – PersonEntity:
          Name:
            NameFull: Peceliunas V
      – PersonEntity:
          Name:
            NameFull: Remes K
      – PersonEntity:
          Name:
            NameFull: Schjesvold F
      – PersonEntity:
          Name:
            NameFull: Abildgaard N
      – PersonEntity:
          Name:
            NameFull: Nahi H
      – PersonEntity:
          Name:
            NameFull: Andersen NF
      – PersonEntity:
          Name:
            NameFull: Vangsted AJ
      – PersonEntity:
          Name:
            NameFull: Klausen TW
      – PersonEntity:
          Name:
            NameFull: Helleberg C
      – PersonEntity:
          Name:
            NameFull: Carlson K
      – PersonEntity:
          Name:
            NameFull: Frølund UC
      – PersonEntity:
          Name:
            NameFull: Axelsson P
      – PersonEntity:
          Name:
            NameFull: Stromberg O
      – PersonEntity:
          Name:
            NameFull: Blimark CH
      – PersonEntity:
          Name:
            NameFull: Crafoord J
      – PersonEntity:
          Name:
            NameFull: Tsykunova G
      – PersonEntity:
          Name:
            NameFull: Eshoj HR
      – PersonEntity:
          Name:
            NameFull: Waage A
      – PersonEntity:
          Name:
            NameFull: Hansson M
      – PersonEntity:
          Name:
            NameFull: Gulbrandsen N
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2022 Jan
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1600-0609
          Numbering:
            – Type: volume
              Value: 108
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: European journal of haematology
              Type: main
ResultId 1